These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8039382)

  • 1. Medical mismanagement in public methadone programs.
    Addiss SS; Horosko S
    Conn Med; 1994 Mar; 58(3):173-4. PubMed ID: 8039382
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampin-induced methadone withdrawal in AIDS.
    Holmes VF
    J Clin Psychopharmacol; 1990 Dec; 10(6):443-4. PubMed ID: 2286719
    [No Abstract]   [Full Text] [Related]  

  • 4. [A methadone-patient's experiences with the Stockholm program].
    Höjd C
    Lakartidningen; 2001 Oct; 98(44):4896. PubMed ID: 11729805
    [No Abstract]   [Full Text] [Related]  

  • 5. [Withdrawal treatment of drug dependent patients with the aim of achieving abstinence].
    Stohler R; Petitjean S; Hörler C; Bardeleben U; Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):10-2. PubMed ID: 8146238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of opioid withdrawal].
    Shaygani S; Waal H
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):114-5. PubMed ID: 19151804
    [No Abstract]   [Full Text] [Related]  

  • 7. [Depressive disorders in management of drug dependent patients. Methadone maintenance].
    Laqueille X; Spadone C
    Encephale; 1995 Dec; 21 Spec No 4():11-4. PubMed ID: 8808339
    [No Abstract]   [Full Text] [Related]  

  • 8. Access to treatment-related and support services in methadone treatment programs.
    Berkman ND; Wechsberg WM
    J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sounding Board. Performance-based rating of methadone maintenance programs.
    Dole VP; Nyswander ME; DesJarlais D; Joseph H
    N Engl J Med; 1982 Jan; 306(3):169-71. PubMed ID: 7054661
    [No Abstract]   [Full Text] [Related]  

  • 10. Self-regulated opioid detoxification by humans: effects of methadone pretreatment.
    McLeod DR; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1982 Apr; 41():232-8. PubMed ID: 6811914
    [No Abstract]   [Full Text] [Related]  

  • 11. Craving despite extremely high methadone dosage.
    de Vos JW; Ufkes JG; van Brussel GH; van den Brink W
    Drug Alcohol Depend; 1996 Mar; 40(3):181-4. PubMed ID: 8861396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of symptom complaints in methadone maintenance patients.
    Dyer KR; White JM
    Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tapering from methadone maintenance: attitudes of clients and staff.
    Gold ML; Sorensen JL; McCanlies N; Trier M; Dlugosch G
    J Subst Abuse Treat; 1988; 5(1):37-44. PubMed ID: 3361625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution of methadone by pharmacies--the Hamburg method].
    Kalke J
    Gesundheitswesen; 1997 Mar; 59(3):181-5. PubMed ID: 9206547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S; Shea J; Switzer J; Turner BJ
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.
    Clarke S; Mulcahy F; Bergin C; Reynolds H; Boyle N; Barry M; Back DJ
    Clin Infect Dis; 2002 Apr; 34(8):1143-5. PubMed ID: 11915005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone.
    Wodak AD; Monheit BM
    Med J Aust; 1990 Dec 3-17; 153(11-12):742. PubMed ID: 2247007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.